Humanitarians working in crisis zones need real-time access to evidence. A recent study from McMaster University in Canada explored the effectiveness of Evidence Aid’s resource collections on critical decision-making
As the collection of literature and resources on the 2019 novel coronavirus outbreak increases, Evidence Aid is working to ensure links to the latest research are made discoverable
Featuring stakeholder opinions on the proposed White House Executive Order on open access in the USA, a new data-sharing declaration and the introduction of a financial incentive for publishing negative results in Germany
Featuring a new database of journal policies, the launch of an open peer review trial in Nature, a summary of one patient advocate’s involvement in cancer research and the call from 21 Nobel laureates for an immediate open access mandate
Featuring the role of open science in combating the coronavirus outbreak, a new journal ranking system to measure research transparency and highlights from this week’s ISMPP U webinar.
The 2020 European Meeting of the International Society for Medical Publication Professionals (ISMPP) opened with a question – in one word, “how do you feel about the future of medical publications?” Answers included “exciting”, “evolving” and “digital”.
Featuring a summary of the updated ICMJE recommendations, the failure of the FDA and the NIH to enforce clinical trial reporting laws, an independent report aiming to improve the transparency of open access services, and the new article format coming to PLOS ONE
Featuring the current predictions for publishing trends in 2020, draft guidance on how to implement the DORA principles in research organizations and a new international observatory to tackle predatory publishers
Featuring Altmetric’s Christmas list, the current status of transformative agreements in relation to Plan S and a review of the ICMJE’s data sharing policy.
Featuring persistent object identifiers for research organizations, an investigation into the standards of reporting randomized clinical trials, the co-production of scientific research and the development of the next set of Good Publication Practice guidelines.